quisqualic acid has been researched along with rofecoxib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellucci, A; Casamenti, F; Giovannini, MG; Pepeu, G; Prosperi, C; Scali, C | 1 |
1 other study(ies) available for quisqualic acid and rofecoxib
Article | Year |
---|---|
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo.
Topics: Alzheimer Disease; Animals; Astrocytes; Brain; Cell Death; Choline O-Acetyltransferase; Cholinergic Fibers; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Encephalitis; Gliosis; Isoenzymes; Lactones; Male; Microglia; Mitogen-Activated Protein Kinases; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Quisqualic Acid; Rats; Rats, Wistar; Sulfones | 2003 |